UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 30, 2024, Gentherm Incorporated (the “Company”) publicly announced its financial results for the third quarter of 2024 and updated 2024 guidance. A copy of the Company’s news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
On October 30, 2024 at 8:00 a.m. Eastern Time, the Company will host a conference call to discuss the third quarter of 2024 financial results. A copy of the supplemental materials that will be used during the conference call is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
The information in Items 2.02 and 7.01 herein and the attached exhibits 99.1 and 99.2 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly stated by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99.1 |
|
Company news release dated October 30, 2024 concerning financial results |
Exhibit 99.2 |
|
|
Exhibit 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
GENTHERM INCORPORATED |
||
|
|
|
|
|
By: |
|
/s/ Wayne Kauffman |
|
|
|
Wayne Kauffman |
|
|
|
Senior Vice President, General Counsel and Secretary |
Date: October 30, 2024 |
|
|
|
|
|
Exhibit 99.1
Gentherm Reports 2024 Third Quarter Results
Strong Outperformance Over Light Vehicle Production
Secured Third Quarter Record $600 Million in Automotive New Business Awards
Updates 2024 Guidance
NORTHVILLE, Michigan, October 30, 2024 /Global Newswire/ -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results for the third quarter ending September 30, 2024.
Third Quarter Highlights
Phil Eyler, the Company's President and CEO, said, “The financial and operating results of the third quarter reflect the continued momentum of our strategy to bring innovation and unique solutions to our customers. Our Automotive Climate and Comfort Solutions revenue outperformed actual light vehicle production in our key markets by nearly 800 basis points. We achieved quarterly automotive new business awards of $600 million, a third quarter record, keeping us on track for annual awards of over $2 billion for the second consecutive year.
He added, “We continue to execute on securing awards and launching new programs, particularly for our new innovative solutions. We had our first market launch of ClimateSense® with a five-zone micro-climate solution on the Cadillac Escalade IQ. Additionally, we won an award for ComfortScale™, our patented, next generation integrated thermal, lumbar and massage system. We have seen an acceleration of new technology wins that we expect will fuel future growth.
He concluded, “Year to date, our relentless focus on operational excellence and financial discipline has yielded not only continued growth over market, but also a nearly 100 basis point expansion in Adjusted EBITDA margin. Including share repurchases in the quarter, we returned more than $100 million dollars to shareholders through share repurchases in the last twelve months. I would like to thank the Gentherm team for their unwavering efforts to drive our business and generate shareholder returns.”
2024 Third Quarter Financial Review
Product revenues for the third quarter of 2024 increased by $5.3 million, or 1.5%, as compared with the prior-year period. Excluding the impact of foreign currency translation, product revenues increased 1.0% year over year.
Automotive revenues increased 1.1% year over year. Adjusting for foreign currency translation, phasing out the non-automotive and contract manufacturing electronics business as well as one-time benefits from recoveries in both periods, Automotive revenues increased 1.2% year over year. Revenues from
|
|
Automotive Climate and Comfort Solutions increased 3.3% in the third quarter compared to the prior-year period.
According to S&P Global Mobility’s mid-October report, actual light vehicle production decreased by 4.5% in the third quarter when compared with the same quarter of 2023 in the Company’s key markets of North America, Europe, China, Japan, and Korea.
Gentherm Medical revenue increased 11.3% year over year, primarily as a result of higher Blanketrol® sales in the U.S., and Astopad® in Europe. Adjusting for the impact of foreign currency translation, Medical revenues increased 10.4%.
See the “Revenues by Product Category and Reconciliation of Foreign Currency Translation Impact” table included below for additional detail.
Gross margin rate increased to 25.5% in the current-year period, as compared with 23.5% in the prior-year period. The increase from the prior-year period was driven by Fit-for-Growth 2.0 initiatives including supplier cost reductions, value engineering activities, as well as the impact of our previously announced exit of the non-automotive electronics business. These were partially offset by annual price reductions and start-up costs from our new plants opening in Monterrey, Mexico and Tangier, Morrocco.
Net research and development expenses of $23.0 million in the quarter were relatively unchanged compared to the prior-year period.
Selling, general and administrative expenses of $36.9 million in the quarter decreased $1.4 million, or 3.6%, versus the prior-year period. The year-over-year decrease was primarily driven by acquisition and integration expenses in the prior year.
Restructuring expenses, net of $2.7 million in the current-year period increased $1.6 million, versus the prior-year period primarily as a result of discrete restructuring activities associated with the Company’s Fit-for-Growth 2.0 initiatives and previously announced footprint optimization.
As described more fully in the “Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDA Margin” table included below, the Company recorded Adjusted EBITDA of $48.1 million in the quarter compared with $47.7 million in the prior-year period, an increase of $0.4 million or 0.9%.
Income tax expense in the quarter was $3.4 million, as compared with $6.9 million in the prior-year period. The effective tax rate was approximately 18% in the quarter.
GAAP diluted earnings per share for the quarter was $0.51 compared with $0.48 for the prior-year period. Adjusted diluted earnings per share, excluding restructuring expenses, net, non-cash purchase accounting impact, non-automotive electronics inventory benefit, unrealized currency loss, and other items specified on the table below, was $0.75. Adjusted diluted earnings per share in the prior-year period was $0.64.
The Company provides various non-GAAP financial measures in this release. See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for investors and limitations, as well as reconciliations below to the most directly comparable GAAP financial measures.
|
|
Guidance
The Company’s full-year 2024 guidance as of October 30, 2024 is shown below:
|
|
As of July 31, 2024 |
|
As of October 30, 2024 (1) |
Product Revenues |
|
Low end of $1.5B – $1.6B |
|
$1.45B – $1.47B |
Adjusted EBITDA Margin Rate |
|
Above mid-point of 12.5% – 13.5% |
|
Near mid-point of 12.5% – 13.5% |
Full-year Adjusted Effective Tax Rate |
|
26% – 29% |
|
No change |
Capital Expenditures |
|
$65M – $75M |
|
No change |
Conference Call
As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13749599.
A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.
A telephonic replay will be available at approximately two hours after the call until 11:59 pm Eastern Time on November 13, 2024. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13749599.
Investor Contact
Gregory Blanchette
investors@gentherm.com
248.308.1702
Media Contact
Melissa Fischer
media@gentherm.com
248.289.9702
About Gentherm
Gentherm (NASDAQ: THRM) is the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats®, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, Morocco, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.
|
|
Forward-Looking Statements
Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:
|
|
The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.
Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Use of Non-GAAP Financial Measures
In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); free cash flow; Net Debt, revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Automotive Climate and Comfort Solutions revenues; and adjusted operating expenses, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock based compensation expenses, and other gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expenses, net, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expenses, net, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified in the reconciliation tables herein. The Company defines Automotive Climate and Comfort Solutions revenues as Automotive revenue excluding specified product revenues and the impact of non-automotive electronics and contract manufacturing electronics revenues. The Company defines adjusted operating expenses as operating expenses excluding impairment of intangible assets and property and equipment, restructuring expenses, net, related non-cash stock based compensation, acquisition, integration and divestiture expenses.
The Company’s reconciliations are included in this release or can be found in the supplemental materials furnished as Exhibit 99.2 to the Company’s Form 8-K dated October 30, 2024.
|
|
In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income (loss), revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.
Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.
|
|
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(Dollars in thousands, except per share data)
(Unaudited)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Product revenues |
|
$ |
371,512 |
|
|
$ |
366,195 |
|
|
$ |
1,103,210 |
|
|
$ |
1,102,143 |
|
Cost of sales |
|
|
276,639 |
|
|
|
279,985 |
|
|
|
822,883 |
|
|
|
846,815 |
|
Gross margin |
|
|
94,873 |
|
|
|
86,210 |
|
|
|
280,327 |
|
|
|
255,328 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net research and development expenses |
|
|
23,013 |
|
|
|
23,150 |
|
|
|
67,619 |
|
|
|
72,991 |
|
Selling, general and administrative expenses |
|
|
36,861 |
|
|
|
38,220 |
|
|
|
116,992 |
|
|
|
113,680 |
|
Restructuring expenses, net |
|
|
2,662 |
|
|
|
1,099 |
|
|
|
12,342 |
|
|
|
3,412 |
|
Impairment of goodwill |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
19,509 |
|
Total operating expenses |
|
|
62,536 |
|
|
|
62,469 |
|
|
|
196,953 |
|
|
|
209,592 |
|
Operating income |
|
|
32,337 |
|
|
|
23,741 |
|
|
|
83,374 |
|
|
|
45,736 |
|
Interest expense, net |
|
|
(4,710 |
) |
|
|
(3,368 |
) |
|
|
(11,956 |
) |
|
|
(9,444 |
) |
Foreign currency (loss) gain |
|
|
(8,480 |
) |
|
|
2,107 |
|
|
|
(6,213 |
) |
|
|
384 |
|
Other income |
|
|
263 |
|
|
|
272 |
|
|
|
952 |
|
|
|
1,058 |
|
Earnings before income tax |
|
|
19,410 |
|
|
|
22,752 |
|
|
|
66,157 |
|
|
|
37,734 |
|
Income tax expense |
|
|
3,445 |
|
|
|
6,908 |
|
|
|
16,531 |
|
|
|
15,478 |
|
Net income |
|
$ |
15,965 |
|
|
$ |
15,844 |
|
|
$ |
49,626 |
|
|
$ |
22,256 |
|
Basic earnings per share |
|
$ |
0.51 |
|
|
$ |
0.48 |
|
|
$ |
1.58 |
|
|
$ |
0.67 |
|
Diluted earnings per share |
|
$ |
0.51 |
|
|
$ |
0.48 |
|
|
$ |
1.57 |
|
|
$ |
0.67 |
|
Weighted average number of shares – basic |
|
|
31,187 |
|
|
|
32,944 |
|
|
|
31,421 |
|
|
|
33,049 |
|
Weighted average number of shares – diluted |
|
|
31,365 |
|
|
|
33,196 |
|
|
|
31,605 |
|
|
|
33,311 |
|
|
|
GENTHERM INCORPORATED
REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT
(Dollars in thousands)
(Unaudited)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|||||||||||||||||
|
|
2024 |
|
|
2023 |
|
% Change |
|
|
2024 |
|
|
2023 |
|
|
% Change |
|
||||||
Climate Control Seat |
|
$ |
115,498 |
|
|
$ |
124,905 |
|
|
(7.5 |
)% |
|
$ |
352,789 |
|
|
$ |
360,868 |
|
|
|
(2.2 |
)% |
Seat Heaters |
|
|
72,982 |
|
|
|
77,238 |
|
|
(5.5 |
)% |
|
|
227,114 |
|
|
|
231,132 |
|
|
|
(1.7 |
)% |
Lumbar and Massage Comfort Solutions |
|
|
48,970 |
|
|
|
33,260 |
|
|
47.2 |
% |
|
|
133,090 |
|
|
|
109,602 |
|
|
|
21.4 |
% |
Steering Wheel Heaters |
|
|
44,711 |
|
|
|
39,861 |
|
|
12.2 |
% |
|
|
126,939 |
|
|
|
115,166 |
|
|
|
10.2 |
% |
Valve Systems |
|
|
26,082 |
|
|
|
27,830 |
|
|
(6.3 |
)% |
|
|
81,974 |
|
|
|
82,516 |
|
|
|
(0.7 |
)% |
Automotive Cables |
|
|
16,834 |
|
|
|
19,668 |
|
|
(14.4 |
)% |
|
|
57,185 |
|
|
|
60,131 |
|
|
|
(4.9 |
)% |
Battery Performance Solutions |
|
|
16,869 |
|
|
|
17,242 |
|
|
(2.2 |
)% |
|
|
46,540 |
|
|
|
57,138 |
|
|
|
(18.5 |
)% |
Electronics |
|
|
10,862 |
|
|
|
10,163 |
|
|
6.9 |
% |
|
|
26,218 |
|
|
|
30,456 |
|
|
|
(13.9 |
)% |
Other Automotive |
|
|
5,996 |
|
|
|
4,615 |
|
|
29.9 |
% |
|
|
15,595 |
|
|
|
21,998 |
|
|
|
(29.1 |
)% |
Subtotal Automotive segment |
|
|
358,804 |
|
|
|
354,782 |
|
|
1.1 |
% |
|
|
1,067,444 |
|
|
|
1,069,007 |
|
|
|
(0.1 |
)% |
Medical segment |
|
|
12,708 |
|
|
|
11,413 |
|
|
11.3 |
% |
|
|
35,766 |
|
|
|
33,136 |
|
|
|
7.9 |
% |
Total Company |
|
$ |
371,512 |
|
|
$ |
366,195 |
|
|
1.5 |
% |
|
$ |
1,103,210 |
|
|
$ |
1,102,143 |
|
|
|
0.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Foreign currency translation impact (a) |
|
|
1,599 |
|
|
|
— |
|
|
|
|
|
(5,134 |
) |
|
|
— |
|
|
|
|
||
Total Company, excluding foreign |
|
$ |
369,913 |
|
|
$ |
366,195 |
|
|
1.0 |
% |
|
$ |
1,108,344 |
|
|
$ |
1,102,143 |
|
|
|
0.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
(a) Foreign currency translation impacts for the Automotive segment and Medical segment were $1,487 and $112 respectively, for the three months ended September 30, 2024. Foreign currency translation impacts for the Automotive segment and Medical segment were $(5,129) and $(5) respectively, for the nine months ended September 30, 2024. |
|
||||||||||||||||||||||
|
|
GENTHERM INCORPORATED
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
AND ADJUSTED EBITDA MARGIN
(Dollars in thousands)
(Unaudited)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Net income |
|
$ |
15,965 |
|
|
$ |
15,844 |
|
|
$ |
49,626 |
|
|
$ |
22,256 |
|
Add back: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Depreciation and amortization |
|
|
12,351 |
|
|
|
12,516 |
|
|
|
38,742 |
|
|
|
38,354 |
|
Income tax expense (a) |
|
|
3,445 |
|
|
|
6,908 |
|
|
|
16,531 |
|
|
|
15,478 |
|
Interest expense, net (b) |
|
|
4,710 |
|
|
|
3,368 |
|
|
|
11,956 |
|
|
|
9,444 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Non-cash stock based compensation (c) |
|
|
2,927 |
|
|
|
3,421 |
|
|
|
10,334 |
|
|
|
8,592 |
|
Restructuring expenses, net |
|
|
2,662 |
|
|
|
1,099 |
|
|
|
12,342 |
|
|
|
3,412 |
|
Non-automotive electronics inventory (benefit) charge |
|
|
(2,679 |
) |
|
|
3,426 |
|
|
|
(4,451 |
) |
|
|
5,489 |
|
Unrealized currency loss (gain) |
|
|
8,604 |
|
|
|
(898 |
) |
|
|
6,251 |
|
|
|
4,227 |
|
Acquisition and integration expenses |
|
|
— |
|
|
|
1,618 |
|
|
|
— |
|
|
|
4,730 |
|
Impairment of goodwill |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
19,509 |
|
Other |
|
|
118 |
|
|
|
372 |
|
|
|
187 |
|
|
|
71 |
|
Adjusted EBITDA |
|
$ |
48,103 |
|
|
$ |
47,674 |
|
|
$ |
141,518 |
|
|
$ |
131,562 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Product revenues |
|
$ |
371,512 |
|
|
$ |
366,195 |
|
|
$ |
1,103,210 |
|
|
$ |
1,102,143 |
|
Net income margin |
|
|
4.3 |
% |
|
|
4.3 |
% |
|
|
4.5 |
% |
|
|
2.0 |
% |
Adjusted EBITDA margin |
|
|
12.9 |
% |
|
|
13.0 |
% |
|
|
12.8 |
% |
|
|
11.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
(a) Includes $2,423 of deferred income tax benefit associated with the goodwill impairment of the Medical reporting unit for the nine months ended September 30, 2023. |
|
|||||||||||||||
(b) Includes $1,157 and $1,161 of interest expense for the three and nine months ended September 30, 2024, related to mark-to-market adjustment of our floating-to-fixed interest rate swap agreement with a notional amount of $100,000. |
|
|||||||||||||||
(c) Includes operating expenses of $2,708 and $3,384 for the three months ended September 30, 2024 and 2023, respectively. Includes operating expenses of $9,717 and $8,218 for the nine months ended September 30, 2024 and 2023, respectively. |
|
|||||||||||||||
|
|
GENTHERM INCORPORATED
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME
AND ADJUSTED EARNINGS PER SHARE
(Dollars in thousands, except per share data)
(Unaudited)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Net income |
|
$ |
15,965 |
|
|
$ |
15,844 |
|
|
$ |
49,626 |
|
|
$ |
22,256 |
|
Non-cash purchase accounting impact |
|
|
1,608 |
|
|
|
1,613 |
|
|
|
4,797 |
|
|
|
5,793 |
|
Restructuring expenses, net |
|
|
2,662 |
|
|
|
1,099 |
|
|
|
12,342 |
|
|
|
3,412 |
|
Unrealized currency loss (gain) |
|
|
8,604 |
|
|
|
(898 |
) |
|
|
6,251 |
|
|
|
4,227 |
|
Non-automotive electronics inventory (benefit) charge |
|
|
(2,679 |
) |
|
|
3,426 |
|
|
|
(4,451 |
) |
|
|
5,489 |
|
Acquisition and integration expenses |
|
|
— |
|
|
|
1,618 |
|
|
|
— |
|
|
|
4,730 |
|
Impairment of goodwill |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
19,509 |
|
Other |
|
|
118 |
|
|
|
372 |
|
|
|
187 |
|
|
|
71 |
|
Tax effect of above |
|
|
(2,695 |
) |
|
|
(1,693 |
) |
|
|
(4,546 |
) |
|
|
(8,635 |
) |
Adjusted net income |
|
$ |
23,583 |
|
|
$ |
21,381 |
|
|
$ |
64,206 |
|
|
$ |
56,852 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
31,187 |
|
|
|
32,944 |
|
|
|
31,421 |
|
|
|
33,049 |
|
Diluted |
|
|
31,365 |
|
|
|
33,196 |
|
|
|
31,605 |
|
|
|
33,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings per share, as reported: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
0.51 |
|
|
$ |
0.48 |
|
|
$ |
1.58 |
|
|
$ |
0.67 |
|
Diluted |
|
$ |
0.51 |
|
|
$ |
0.48 |
|
|
$ |
1.57 |
|
|
$ |
0.67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
0.76 |
|
|
$ |
0.65 |
|
|
$ |
2.04 |
|
|
$ |
1.72 |
|
Diluted |
|
$ |
0.75 |
|
|
$ |
0.64 |
|
|
$ |
2.03 |
|
|
$ |
1.71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED BALANCE SHEETS
(Dollars in thousands, except share data)
(Unaudited)
|
|
September 30, 2024 |
|
|
December 31, 2023 |
|
||
ASSETS |
|
|
|
|
|
|
||
Current Assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
150,581 |
|
|
$ |
149,673 |
|
Accounts receivable, net |
|
|
270,913 |
|
|
|
253,579 |
|
Inventory: |
|
|
|
|
|
|
||
Raw materials |
|
|
141,547 |
|
|
|
126,013 |
|
Work in process |
|
|
20,116 |
|
|
|
15,704 |
|
Finished goods |
|
|
72,083 |
|
|
|
64,175 |
|
Inventory, net |
|
|
233,746 |
|
|
|
205,892 |
|
Other current assets |
|
|
81,711 |
|
|
|
78,420 |
|
Total current assets |
|
|
736,951 |
|
|
|
687,564 |
|
Property and equipment, net |
|
|
253,531 |
|
|
|
245,234 |
|
Goodwill |
|
|
104,839 |
|
|
|
104,073 |
|
Other intangible assets, net |
|
|
61,067 |
|
|
|
66,482 |
|
Operating lease right-of-use assets |
|
|
29,366 |
|
|
|
27,358 |
|
Deferred income tax assets |
|
|
81,923 |
|
|
|
81,930 |
|
Other non-current assets |
|
|
30,502 |
|
|
|
21,730 |
|
Total assets |
|
$ |
1,298,179 |
|
|
$ |
1,234,371 |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
||
Current Liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
254,555 |
|
|
$ |
215,827 |
|
Current lease liabilities |
|
|
7,038 |
|
|
|
7,700 |
|
Current maturities of long-term debt |
|
|
210 |
|
|
|
621 |
|
Other current liabilities |
|
|
103,647 |
|
|
|
100,805 |
|
Total current liabilities |
|
|
365,450 |
|
|
|
324,953 |
|
Long-term debt, less current maturities |
|
|
222,104 |
|
|
|
222,217 |
|
Non-current lease liabilities |
|
|
21,929 |
|
|
|
16,175 |
|
Pension benefit obligation |
|
|
2,805 |
|
|
|
3,209 |
|
Other non-current liabilities |
|
|
25,182 |
|
|
|
23,095 |
|
Total liabilities |
|
$ |
637,470 |
|
|
$ |
589,649 |
|
Shareholders’ equity: |
|
|
|
|
|
|
||
Common Stock: |
|
|
|
|
|
|
||
No par value; 55,000,000 shares authorized 30,976,821 and 31,542,001 issued and outstanding at September 30, 2024 and December 31, 2023, respectively |
|
|
10,698 |
|
|
|
50,503 |
|
Paid-in capital |
|
|
4,552 |
|
|
|
— |
|
Accumulated other comprehensive loss |
|
|
(35,021 |
) |
|
|
(30,160 |
) |
Accumulated earnings |
|
|
680,480 |
|
|
|
624,379 |
|
Total shareholders’ equity |
|
|
660,709 |
|
|
|
644,722 |
|
Total liabilities and shareholders’ equity |
|
$ |
1,298,179 |
|
|
$ |
1,234,371 |
|
|
|
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
|
|
Nine Months Ended September 30, |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Operating Activities: |
|
|
|
|
|
|
||
Net income |
|
$ |
49,626 |
|
|
$ |
22,256 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
40,085 |
|
|
|
38,531 |
|
Deferred income taxes |
|
|
1,568 |
|
|
|
(3,017 |
) |
Stock based compensation |
|
|
10,291 |
|
|
|
8,451 |
|
(Gain) loss on disposition of property and equipment |
|
|
(1,702 |
) |
|
|
873 |
|
Provisions for inventory |
|
|
502 |
|
|
|
6,597 |
|
Impairment of goodwill |
|
|
— |
|
|
|
19,509 |
|
Other |
|
|
(1,057 |
) |
|
|
81 |
|
Changes in assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable, net |
|
|
(16,179 |
) |
|
|
(19,813 |
) |
Inventory |
|
|
(27,826 |
) |
|
|
3,733 |
|
Other assets |
|
|
(35,959 |
) |
|
|
(19,218 |
) |
Accounts payable |
|
|
38,501 |
|
|
|
32,158 |
|
Other liabilities |
|
|
15,239 |
|
|
|
(10,099 |
) |
Net cash provided by operating activities |
|
|
73,089 |
|
|
|
80,042 |
|
Investing Activities: |
|
|
|
|
|
|
||
Purchases of property and equipment |
|
|
(50,354 |
) |
|
|
(26,526 |
) |
Proceeds from the sale of property and equipment |
|
|
7,537 |
|
|
|
72 |
|
Proceeds from deferred purchase price of factored receivables |
|
|
10,266 |
|
|
|
10,139 |
|
Cost of technology investments |
|
|
(590 |
) |
|
|
(630 |
) |
Net cash used in investing activities |
|
|
(33,141 |
) |
|
|
(16,945 |
) |
Financing Activities: |
|
|
|
|
|
|
||
Borrowings on debt |
|
|
53,000 |
|
|
|
— |
|
Repayments of debt |
|
|
(53,520 |
) |
|
|
(27,166 |
) |
Proceeds from the exercise of Common Stock options |
|
|
4,650 |
|
|
|
263 |
|
Taxes withheld and paid on employees' stock based compensation |
|
|
(3,157 |
) |
|
|
(2,754 |
) |
Cash paid for the repurchase of Common Stock |
|
|
(41,578 |
) |
|
|
(31,094 |
) |
Net cash used in financing activities |
|
|
(40,605 |
) |
|
|
(60,751 |
) |
Foreign currency effect |
|
|
1,565 |
|
|
|
(1,883 |
) |
Net increase in cash and cash equivalents |
|
|
908 |
|
|
|
463 |
|
Cash and cash equivalents at beginning of period |
|
|
149,673 |
|
|
|
153,891 |
|
Cash and cash equivalents at end of period |
|
$ |
150,581 |
|
|
$ |
154,354 |
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
||
Cash paid for taxes |
|
$ |
19,470 |
|
|
$ |
18,893 |
|
Cash paid for interest |
|
|
10,022 |
|
|
|
9,737 |
|
|
|
GENTHERM INCORPORATED
OTHER NON-GAAP RECONCILIATIONS
(Dollars in thousands)
(Unaudited)
|
|
Three Months Ended September 30, |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Automotive revenues |
|
$ |
358,804 |
|
|
$ |
354,782 |
|
Non-automotive electronics revenues and contract manufacturing electronics |
|
|
5,985 |
|
|
|
7,321 |
|
One-time benefits from recoveries and retrofits |
|
|
— |
|
|
|
140 |
|
Adjusted Automotive revenues |
|
|
352,819 |
|
|
|
347,321 |
|
Foreign currency translation impact |
|
|
1,467 |
|
|
|
— |
|
Adjusted Automotive revenues, excluding foreign currency translation impact |
|
$ |
351,352 |
|
|
$ |
347,321 |
|
Year over Year % change |
|
|
1.2 |
% |
|
|
|
|
|
|
Three Months Ended September 30, |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Automotive revenues |
|
$ |
358,804 |
|
|
$ |
354,782 |
|
Less: Valve Systems |
|
|
26,082 |
|
|
|
27,830 |
|
Less: Automotive Cables |
|
|
16,834 |
|
|
|
19,668 |
|
Less: Battery Performance Solutions |
|
|
16,869 |
|
|
|
17,242 |
|
Less: Non-automotive and contract manufacturing electronics |
|
|
5,985 |
|
|
|
7,321 |
|
Automotive Climate and Comfort Solutions revenues |
|
|
293,034 |
|
|
|
282,721 |
|
Less: One-time benefits from recoveries and retrofits |
|
|
— |
|
|
|
140 |
|
Adjusted Automotive Climate and Comfort Solutions revenues |
|
|
293,034 |
|
|
|
282,581 |
|
Foreign currency translation impact |
|
|
1,024 |
|
|
|
— |
|
Adjusted Automotive Climate and Comfort Solutions revenues, excluding foreign currency translation impact |
|
$ |
292,010 |
|
|
$ |
282,581 |
|
Year over Year % change |
|
|
3.3 |
% |
|
|
|
|
Proprietary © Gentherm 2024 2024 Third Quarter Results October 30, 2024 Exhibit 99.2
Use of Non-GAAP Financial Measures* In addition to the results reported herein in accordance with GAAP, the Company has provided here or may discuss on the related conference call adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); free cash flow; Net Debt; revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Automotive Climate and Comfort Solutions revenues; and adjusted operating expenses, each a non-GAAP financial measure. See the Company’s earnings release dated October 30, 2024, for the definitions of each non-GAAP financial measure, information regarding why the Company utilizes such non-GAAP measures as supplemental measures of performance or liquidity, and their limitations, and for certain reconciliations of GAAP to non-GAAP historical financial measures. * See Appendix for certain reconciliations of GAAP to non-GAAP historical financial measures. Proprietary © Gentherm 2024
Forward-Looking Statements Proprietary © Gentherm 2024 Except for historical information contained herein, statements in this presentation are forward-looking statements that are made by Gentherm Incorporated (the “Company”) pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements that address future operating, financial or business performance or strategies or expectations are forward-looking statements. The forward-looking statements included in this presentation are made as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we consider appropriate under the circumstances. Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The forward-looking statements are subject to a number of important assumptions, risks, uncertainties and other factors that may cause actual results or performance to differ materially from that expressed or implied by such statements. For a discussion of these risks and uncertainties and other factors, please see the Company’s most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission, including “Risk Factors.” In addition, the business outlook discussed in this presentation does not include the potential impact of any business combinations, acquisitions, divestitures, strategic investments and other significant transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.
2024 Priorities Proprietary © Gentherm 2024 4 Laser focused on key priorities to drive operational execution, profitability improvement and innovation Execute on Fit-for-Growth 2.0 initiatives to expand margin Deliver industry leading proprietary innovations such as ClimateSense®, WellSenseTM and ComfortScaleTM 03 Lead the industry with Automotive New Business Awards and execute on unprecedented award backlog
Automotive Highlights 30 Vehicle launches with 11 OEMs Multiple CCS® Launches Proprietary © Gentherm 2024 5 The DEI Employer® Awards, & Reuters D.R.I.V.E. Honours 2024 Empowering Women Award ClimateSense® launch on Cadillac Escalade IQ Record quarterly revenue for pneumatic lumbar and massage solutions Cadillac Escalade IQ Kia K4 BMW 5-Series Skoda Kodiaq Audi A5 Volkswagen Passat Pro Yangwang U9 Volkswagen Magotan
New Automotive Business Awards $600M in awards in 3Q Honda Pilot EV heated interior award Proprietary © Gentherm 2024 6 Continued strong demand for thermal comfort, massage and lumbar solutions CCS® Awards from: Hyundai | Honda | Toyota | Audi Large EV Manufacturer | Great Wall Expanding business with Chinese Domestic OEMs including Leap Motor and Xiaomi’s Mi Auto 13 Steering Wheel Heater Awards, including 8 hands-on-detection enabled awards, including the GM Full Size Truck and Large SUV platforms
First ComfortScale™ Award Our patented, fully integrated, modular thermal and pneumatic lumbar and massage solution creates customer value and adds content per vehicle General Motors: Truck platform including Chevrolet Silverado & GMC Sierra PCS™ Lumbar Support PCS™ Massage CCS® Vent CCS® Heat Multifunction ECU ClimateSense® Software Proprietary © Gentherm 2024 7 01 Flexible design provides ability to be foam and seat agnostic, adaptable for all OEMs and Seat Tier 1’s 03 Scalable system from lumbar only to fully contented pneumatic and thermal solutions 02 Unmatched performance with demonstratable improvement in time to occupant comfort resulting in an enhanced user experience 04 Easy and quick to integrate design enables running changes 05 Lower cost and complexity reducing seat assembly time for JIT partners CCI™ Steering Wheel Heat
Medical Highlights Proprietary © Gentherm 2024 8 Proprietary © Gentherm 2024 8 Year-over-year revenue growth Quarterly revenue increased 10%, ex-fx Strong growth of flagship Blanketrol continues in the U.S., highlighted by a key win with the U.S. Navy Driving organic revenue growth and improved profitability Strong partner execution in Europe, Middle East & Africa continues to produce growth in the Region
(Dollars in thousands, except per share data) 2024 2023 2024 2023 Product Revenues $ 371,512 $ 366,195 $ 1,103,210 $ 1,102,143 Automotive 358,804 354,782 1,067,444 1,069,007 Medical 12,708 11,413 35,766 33,136 Gross Margin 94,873 86,210 280,327 255,328 Gross Margin % 25.5 % 23.5 % 25.4 % 23.2 % Operating Expenses 62,536 62,469 196,953 209,592 Operating Income 32,337 23,741 83,374 45,736 Adjusted EBITDA 48,103 47,674 141,518 131,562 Adjusted EBITDA Margin 12.9 % 13.0 % 12.8 % 11.9 % Diluted EPS - As Adjusted $ 0.75 $ 0.64 $ 2.03 $ 1.71 Select Income Statement Data Proprietary © Gentherm 2024 9 Three Months Ended September 30 Nine Months Ended September 30
Select Balance Sheet Data September 30, 2024 June 30, 2023 December 31, 2023 December 31, 2022 December 31, 2022 Cash and Cash Equivalents $ 150,581 $ 149,673 Total Assets 1,298,179 1,234,371 Debt 222,314 222,838 Current 210 621 Non-Current 222,104 222,217 Revolving LOC Availability 278,000 278,000 Total Liquidity 428,581 427,673 Proprietary © Gentherm 2024 10 (Dollars in thousands)
Proprietary © Gentherm 2024 11 2024 Guidance As of July 31, 2024 As of October 30, 2024(1) Product Revenues Low end of $1.5B - $1.6B $1.45B – $1.47B Adjusted EBITDA Margin Rate Above mid-point of 12.5% - 13.5% Near mid-point of 12.5% – 13.5% Adjusted Effective Tax Rate 26% - 29% No change Capital Expenditures $65M - $75M No change Based on the current forecast of customer orders, our expectations of near-term conditions, and light vehicle production in our relevant markets decreasing at low to mid single digit rate for full year 2024 versus 2023, and a EUR to USD exchange rate of $1.08/Euro. Due to the inherent difficulty of forecasting the timing and amount of certain items that would impact net income margin, such as foreign currency gains and losses, we are unable to reasonably estimate net income margin, the GAAP financial measure most directly comparable to Adjusted EBITDA margin. Accordingly, we are unable to provide a reconciliation of Adjusted EBITDA margin to net income margin with respect to the guidance provided.
Appendix Proprietary © Gentherm 2024
Proprietary © Gentherm 2024 13 Reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin Three Months Ended September 30 2024 2023 2024 2023 Net Income $ 15,965 $ 15,844 $ 49,626 $ 22,256 Add Back: Income Tax Expense 3,445 6,908 16,531 15,478 Interest Expense, net 4,710 3,368 11,956 9,444 Depreciation and Amortization 12,351 12,516 38,742 38,354 Adjustments: Restructuring Expenses, net 2,662 1,099 12,342 3,412 Unrealized Currency Loss (Gain) 8,604 (898 ) 6,251 4,227 Acquisition and Integration Expenses ─ 1,618 ─ 4,730 Non-Automotive Electronics Inventory (Benefit) Charge (2,679 ) 3,426 (4,451 ) 5,489 Impairment of Goodwill ─ ─ ─ 19,509 Non-Cash Stock Based Compensation 2,927 3,421 10,334 8,592 Other 118 372 187 71 Adjusted EBITDA $ 48,103 $ 47,674 $ 141,518 $ 131,562 Product Revenues $ 371,512 $ 366,195 $ 1,103,210 $ 1,102,143 Net Income Margin 4.3 % 4.3 % 4.5 % 2.0 % Adjusted EBITDA Margin 12.9 % 13.0 % 12.8 % 11.9 % Nine Months Ended September 30
Proprietary © Gentherm 2024 14 Reconciliation of Adjusted EPS 2024 2023 2024 2023 Diluted EPS - As Reported $ 0.51 $ 0.48 $ 1.57 $ 0.67 Acquisition and Integration Expenses ─ 0.05 ─ 0.14 Non-Cash Purchase Accounting Impacts 0.05 0.05 0.15 0.17 Unrealized Currency Loss (Gain) 0.27 (0.03 ) 0.20 0.13 Restructuring Expenses, net 0.08 0.03 0.39 0.10 Non-Automotive Electronics Inventory (Benefit) Charge (0.09 ) 0.10 (0.14 ) 0.16 Impairment of Goodwill ─ ─ ─ 0.59 Other ─ (0.01 ) 0.01 ─ Tax Effect of Above (0.09 ) (0.05 ) (0.14 ) (0.26 ) Rounding 0.02 ─ (0.01 ) 0.01 Diluted EPS - As Adjusted $ 0.75 $ 0.64 $ 2.03 $ 1.71 Three Months Ended September 30 Nine Months Ended September 30